Literature DB >> 21778703

Trace fear conditioning detects hypoxic-ischemic brain injury in neonatal mice.

Katarina Järlestedt1, Alison L Atkins, Henrik Hagberg, Marcela Pekna, Carina Mallard.   

Abstract

Trace fear conditioning is a well-established test for the assessment of learning deficits in rodents. The aim of this study was to determine whether hypoxia-ischemia (HI) on postnatal day 9 (P9) in mice prevents the acquisition and expression of cued and contextual fear learning in early adulthood. Brain injury was induced in mice on P9 by 30 min of HI. On P49 and P50, animals were tested for: (1) trace fear conditioning with a short delay (2 s) between a shock-paired tone plus light and shock, (2) trace fear conditioning with a longer delay (20 s) between a shock-paired tone and shock, and (3) trace fear conditioning with a 2-second delay between a shock-paired tone and shock with additional visual, olfactory and tactile contextual cues in the fear conditioning apparatus. Outcome was assessed as percent of time spent freezing during a 2-min test. Histological assessment of the hippocampus and amygdala was performed on P51 to determine the extent of HI injury. Both shock-paired tone plus light with a short delay and shock-paired tone with a short delay plus additional contextual cues enhanced tone-induced freezing behavior in a nonhandled control group, but not in the HI group. For trace fear conditioning with a 20-second delay between the tone and the shock, freezing behavior did not differ significantly between nonhandled control and HI animals. Dorsal hippocampal and amygdala volumes were smaller in the ischemic hemispheres of the HI mice that displayed impaired fear memory with shock-paired tone plus light. In summary, we have shown that trace fear conditioning is a sensitive method for detecting memory impairments in adolescent mice following mild HI injury during the neonatal period. Combining a discrete conditioned stimulus (shock-paired tone plus light) with a short trace delay was the most sensitive method for using the fear conditioning paradigm to detect mild HI damage to the hippocampus and amygdala.
Copyright © 2011 S. Karger AG, Basel.

Entities:  

Mesh:

Year:  2011        PMID: 21778703     DOI: 10.1159/000329710

Source DB:  PubMed          Journal:  Dev Neurosci        ISSN: 0378-5866            Impact factor:   2.984


  6 in total

1.  Increased anxiety-like behaviors, but blunted cortisol stress response after neonatal hippocampal lesions in monkeys.

Authors:  Jessica Raper; Mark Wilson; Mar Sanchez; Christa Payne; Jocelyne Bachevalier
Journal:  Psychoneuroendocrinology       Date:  2016-11-18       Impact factor: 4.905

Review 2.  Rodent Gymnastics: Neurobehavioral Assays in Ischemic Stroke.

Authors:  Sreekala S Nampoothiri; Tanvi Potluri; Harshith Subramanian; Rajanikant G Krishnamurthy
Journal:  Mol Neurobiol       Date:  2016-10-17       Impact factor: 5.590

3.  Neuroprotection by the histone deacetylase inhibitor trichostatin A in a model of lipopolysaccharide-sensitised neonatal hypoxic-ischaemic brain injury.

Authors:  Bobbi Fleiss; Marie K L Nilsson; Klas Blomgren; Carina Mallard
Journal:  J Neuroinflammation       Date:  2012-04-18       Impact factor: 8.322

4.  Decreased survival of newborn neurons in the dorsal hippocampus after neonatal LPS exposure in mice.

Authors:  K Järlestedt; A S Naylor; J Dean; H Hagberg; C Mallard
Journal:  Neuroscience       Date:  2013-08-30       Impact factor: 3.590

5.  C3a Receptor Signaling Inhibits Neurodegeneration Induced by Neonatal Hypoxic-Ischemic Brain Injury.

Authors:  Andrea Pozo-Rodrigálvarez; YiXian Li; Anna Stokowska; Jingyun Wu; Verena Dehm; Hana Sourkova; Harry Steinbusch; Carina Mallard; Henrik Hagberg; Milos Pekny; Marcela Pekna
Journal:  Front Immunol       Date:  2021-12-17       Impact factor: 7.561

Review 6.  Targeting Complement C3a Receptor to Improve Outcome After Ischemic Brain Injury.

Authors:  Marcela Pekna; Anna Stokowska; Milos Pekny
Journal:  Neurochem Res       Date:  2021-08-11       Impact factor: 3.996

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.